Literature DB >> 19018979

Liver stiffness measurement using FibroScan is influenced by serum total bilirubin in acute hepatitis.

Seung Up Kim1, Kwang-Hyub Han, Jun Yong Park, Sang Hoon Ahn, Moon Jae Chung, Chae Yoon Chon, Eun Hee Choi, Do Young Kim.   

Abstract

BACKGROUND: Liver stiffness measurement (LSM) using FibroScan is accepted as a highly reproducible and accurate technique for assessment of liver fibrosis. However, several studies have indicated that the LSM value can be significantly influenced by major changes in aminotransferases in patients with chronic viral hepatitis and LSM is unreliable for diagnosing underlying liver cirrhosis in patients with acute liver damage. We aimed to determine biochemical factors influencing the LSM value in patients with acute hepatitis.
METHODS: From July to December 2007, a total of 60 patients with acute hepatitis of varying aetiologies were recruited prospectively. LSM and biochemical tests were performed at diagnosis and recovery from acute hepatitis.
RESULTS: The mean age of the patients (38 men and 22 women) was 40.7+/-15.4 years. The aetiology of acute hepatitis included hepatitis A virus in 31 patients, drug induced in 19 and hepatitis B virus in 10. The mean LSM value was 19.6 kPa at diagnosis and 15.9 kPa at recovery. Correlation analysis showed that the LSM value at diagnosis was significantly associated with platelet count (P=0.023), alanine aminotransferase (P=0.045), albumin (P<0.001), total bilirubin (P=0.004) and prothrombin time (P=0.005). However, additional correlation analysis between the changes in LSM value and biochemical factors from diagnosis to recovery showed that the change in total bilirubin was found to be the only factor associated with the change in the LSM value (P<0.001).
CONCLUSIONS: Our data suggest that the LSM value might be influenced by serum total bilirubin in patients with acute hepatitis without pre-existing underlying chronic liver disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19018979     DOI: 10.1111/j.1478-3231.2008.01894.x

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


  18 in total

1.  Liver stiffness measurement using acoustic radiation force impulse (ARFI) elastography and effect of necroinflammation.

Authors:  Ki Tae Yoon; Sun Min Lim; Jun Yong Park; Do Young Kim; Sang Hoon Ahn; Kwang-Hyub Han; Chae Yoon Chon; Mong Cho; Jun Woo Lee; Seung Up Kim
Journal:  Dig Dis Sci       Date:  2012-06       Impact factor: 3.199

Review 2.  Noninvasive assessment of alcoholic liver disease using unidimensional transient elastography (Fibroscan(®)).

Authors:  Monica Lupsor-Platon; Radu Badea
Journal:  World J Gastroenterol       Date:  2015-11-14       Impact factor: 5.742

3.  Non-invasive assessment of changes in liver fibrosis via liver stiffness measurement in patients with chronic hepatitis B: impact of antiviral treatment on fibrosis regression.

Authors:  Seung Up Kim; Jun Yong Park; Do Young Kim; Sang Hoon Ahn; Eun Hee Choi; Jae Yeon Seok; Jung Min Lee; Young Nyun Park; Chae Yoon Chon; Kwang-Hyub Han
Journal:  Hepatol Int       Date:  2010-08-04       Impact factor: 6.047

4.  Doppler ultrasound of hepatic blood flow for noninvasive evaluation of liver fibrosis compared with liver biopsy and transient elastography.

Authors:  H H Lutz; N Gassler; F W Tischendorf; C Trautwein; J J W Tischendorf
Journal:  Dig Dis Sci       Date:  2012-04-10       Impact factor: 3.199

Review 5.  Non-invasive diagnosis of hepatitis B virus-related cirrhosis.

Authors:  Sangheun Lee; Do Young Kim
Journal:  World J Gastroenterol       Date:  2014-01-14       Impact factor: 5.742

6.  How intrahepatic cholestasis affects liver stiffness in patients with chronic hepatitis B: a study of 1197 patients with liver biopsy.

Authors:  Huanyi Guo; Mei Liao; Jieyang Jin; Jie Zeng; Shuoyang Li; Darrell R Schroeder; Jian Zheng; Rongqin Zheng; Shigao Chen
Journal:  Eur Radiol       Date:  2019-10-30       Impact factor: 5.315

7.  Discordance between liver biopsy and Fibroscan® in assessing liver fibrosis in chronic hepatitis b: risk factors and influence of necroinflammation.

Authors:  Seung Up Kim; Ja Kyung Kim; Young Nyun Park; Kwang-Hyub Han
Journal:  PLoS One       Date:  2012-02-23       Impact factor: 3.240

8.  Dynamics of the liver stiffness value using transient elastography during the perioperative period in patients with valvular heart disease.

Authors:  Young Eun Chon; Seung Up Kim; Jun Yong Park; Do Young Kim; Sang Hoon Ahn; Kwang-Hyub Han; Chae Yoon Chon; Sak Lee
Journal:  PLoS One       Date:  2014-03-26       Impact factor: 3.240

9.  Factors affecting the accuracy of controlled attenuation parameter (CAP) in assessing hepatic steatosis in patients with chronic liver disease.

Authors:  Kyu Sik Jung; Beom Kyung Kim; Seung Up Kim; Young Eun Chon; Kyeong Hyeon Chun; Kyung Hyun Cheon; Sung Bae Kim; Sang Hoon Lee; Sung Soo Ahn; Jun Yong Park; Do Young Kim; Sang Hoon Ahn; Young Nyun Park; Kwang-Hyub Han
Journal:  PLoS One       Date:  2014-06-05       Impact factor: 3.240

10.  Relationship of liver stiffness and controlled attenuation parameter measured by transient elastography with diabetes mellitus in patients with chronic liver disease.

Authors:  Jem Ma Ahn; Yong-Han Paik; So Hyun Kim; Jun Hee Lee; Ju Yeon Cho; Won Sohn; Geum-Youn Gwak; Moon Seok Choi; Joon Hyeok Lee; Kwang Cheol Koh; Seung Woon Paik; Byung Chul Yoo
Journal:  J Korean Med Sci       Date:  2014-07-30       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.